LoadingLoadingLoading28 funds hold it.Insiders net selling.
Net selling: insiders sold $1.5M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 28, 2026
Financial period
Q3 2026
Earnings per share
$4.64 expected
Revenue
$3.76B expected
FY 2026 guidance
$14.78B to $14.89B
No comparable estimate
Estimates as of Nov 3, 2026
EPS expected
$4.34 to $4.61
Revenue expected
11 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 28, 2026 | $4.78est. $4.64 | +2.94%beat | $3.81Best. $3.76B+1.35% | +6.9%from $3.56B |
| Jun 30, 2026Reported Jul 30, 2026 | $4.99est. $4.77 | +4.65%beat | $3.73BCompany release | +5.8%from $3.53B |
| Mar 31, 2026Reported Apr 30, 2026 | $4.25est. $4.12 | +3.26%beat | $3.54BSEC filing | +5.8%from $3.35B |
| Dec 31, 2025Reported Feb 17, 2026 | $4.07est. $3.94 | +3.25%beat | $3.52BAlpha Vantage | +5.6%from $3.33B |
| Sep 30, 2025Reported Oct 28, 2025 | $4.18est. $4.14 | +0.97%in line | $3.56BSEC filing | +8.6%from $3.28B |
| Jun 30, 2025Reported Jul 24, 2025 | $4.35est. $4.16 | +4.57%beat | $3.53BSEC filing | +9.5%from $3.22B |
| Mar 31, 2025Reported Apr 29, 2025 | $3.84est. $3.73 | +2.95%beat | $3.35BSEC filing | +5.3%from $3.18B |
| Dec 31, 2024Reported Feb 6, 2025 | $3.45est. $3.39 | +1.77%beat | $3.33BAlpha Vantage | +9.8%from $3.03B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $3.52B | $3.54B | $3.73B | $3.81B |
| Cost of what it sold | $2.60B | $2.60B | $2.62B | $2.70B |
| Gross profit | $920.6M | $938.2M | $1.11B | $1.11B |
| What it spent | ||||
| Sales and admin | $538.6M | $551.0M | $577.2M | $611.4M |
| Other operating costs | — | — | $83.2M | $94.6M |
| Total operating expenses | $538.6M | $551.0M | $660.4M | $706.0M |
| What was left | ||||
| Operating profit | $382.0M | $387.2M | $451.6M | $402.1M |
| Interest on debt | $55.0M | $55.1M | $61.1M | $59.1M |
| Profit before tax | $190.6M | $319.7M | $386.4M | $328.0M |
| Tax | $25.7M | $41.7M | $87.3M | $64.9M |
| Net profit | $164.7M | $277.8M | $298.7M | $262.8M |
| EBITDA | $418.6M | $548.1M | $620.9M | $570.1M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
What Labcorp Holdings Shares Earnings Beat Means For Shareholders
Leans bullishNov 7PacBio (PACB) Q3 2026 Earnings Call: SPRQ-Nx-Einführung und eingeengte Umsatzprognose
NeutralNov 6Q3 revenue slips to $202.7M as Myriad Genetics (MYGN) posts a wider net loss.
Leans bullishNov 621,926 Shares in Labcorp Holdings Inc. $LH Purchased by Mirae Asset Global Investments Co. Ltd.
BullishNov 6Natera Inc (NTRA) Q3 2026 Earnings Call Highlights: Revenue Jumps 34% as Guidance Raised Above ...
NeutralNov 6How Investors May Respond To AMN Healthcare Services Stock After Profit Turnaround
NeutralNov 6OPKO Health (NASDAQ:OPK) Director John Paganelli Sells 9,175 Shares of Company Stock
Leans bullishNov 5Missed NeoGenomics' Rally? Here Is What Holders Saw
NeutralNov 5
